PlainRecalls
FDA Drug Moderate Class II Terminated

Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05

Reported: December 31, 2014 Initiated: December 23, 2014 #D-0325-2015

Product Description

Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05

Reason for Recall

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Details

Units Affected
19,536 units
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 19,536 units.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 31, 2014. Severity: Moderate. Recall number: D-0325-2015.